IMPRIMIS PHARMACEUTICALS INC's ticker is IMMY and the CUSIP is 45323A201. A total of 20 filers reported holding IMPRIMIS PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $427,000 | +53.6% | 75,000 | -25.0% | 0.11% | +189.2% |
| Q3 2018 | $278,000 | +26.4% | 100,000 | 0.0% | 0.04% | +12.1% |
| Q2 2018 | $220,000 | +77.4% | 100,000 | +42.9% | 0.03% | +73.7% |
| Q1 2018 | $124,000 | +45.9% | 70,000 | +40.0% | 0.02% | +90.0% |
| Q4 2017 | $85,000 | +165.6% | 50,000 | +150.0% | 0.01% | +150.0% |
| Q3 2017 | $32,000 | -75.0% | 20,000 | -50.0% | 0.00% | -63.6% |
| Q2 2017 | $128,000 | +204.8% | 40,000 | +300.0% | 0.01% | +57.1% |
| Q1 2017 | $42,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,722,000 | $9,798,000 | 3.66% |
| Diametric Capital, LP | 252,160 | $1,453,000 | 1.12% |
| Birchview Capital, LP | 180,000 | $1,024,000 | 0.97% |
| EAM Global Investors LLC | 206,445 | $1,175,000 | 0.64% |
| EAM Investors, LLC | 301,415 | $1,715,000 | 0.47% |
| BARD ASSOCIATES INC | 51,550 | $293,000 | 0.17% |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 85,569 | $487,000 | 0.11% |
| ARDSLEY ADVISORY PARTNERS LP | 75,000 | $427,000 | 0.11% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 112,859 | $642,000 | 0.04% |
| ELLINGTON MANAGEMENT GROUP LLC | 16,500 | $94,000 | 0.03% |